a developer of antibody drug conjugates to improve patient outcomes in multiple oncology indications
Industry Biotechnology
A.I.dvisor indicates that over the last year, MRSN has been loosely correlated with CRNX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MRSN jumps, then CRNX could also see price increases.
Ticker / NAME | Correlation To MRSN | 1D Price Change % | ||
---|---|---|---|---|
MRSN | 100% | -1.93% | ||
CRNX - MRSN | 41% Loosely correlated | +1.35% | ||
MLYS - MRSN | 39% Loosely correlated | +1.56% | ||
VRDN - MRSN | 38% Loosely correlated | -3.34% | ||
IPSC - MRSN | 38% Loosely correlated | N/A | ||
BEAM - MRSN | 37% Loosely correlated | -1.21% | ||
More |